Noticias de ABBV

29/04/2026 ABBV_US — GuruFocus

29/04/2026 ABBV_US — GuruFocus ES ← EN

Howard Hughes Medical Institute's AbbVie Inc(ABBV) Holding History

29/04/2026 ABBV_US — Stock Titan ES ← EN

Vanguard (ABBV) holds 132.9M shares, a 7.51% stake in AbbVie

29/04/2026 ABBV_US — MarketWatch ES ← EN

AbbVie Inc. stock outperforms competitors on strong trading day

29/04/2026 ABBV_US — MarketWatch

29/04/2026 ABBV_US — Morningstar

29/04/2026 ABBV_US — Benzinga

29/04/2026 ABBV_US — Barron's ES ← EN

AbbVie Beats Earnings Estimates, Boosts 2026 Outlook. What It Means for the Stock.

29/04/2026 ABBV_US — BioSpace ES ← EN

AbbVie tops Q1 estimates, raises outlook and discontinues cancer candidate

29/04/2026 ABBV_US — AlphaStreet ES ← EN

AbbVie Releases Q1 2026 Financial Results

29/04/2026 ABBV_US — Law360 ES ← EN

AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit

29/04/2026 ABBV_US — news.google.com ES ← EN

Research Alert: CFRA Retains Buy Rating On Shares Of Abbvie Inc.

29/04/2026 ABBV_US — AASTOCKS.com ES ← EN

AbbVie Inc. (ABBV.US) 1Q EPS Beats; Raises FY2026 Outlook

29/04/2026 ABBV_US — MSN ES ← EN

AbbVie lifts forecast and defends Skyrizi after rivals loom

29/04/2026 ABBV_US — Crain's Chicago Business

29/04/2026 ABBV_US — Yahoo Finance ES ← EN

AbbVie (ABBV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

29/04/2026 ABBV_US — Seeking Alpha ES ← EN

Near the top of biotech rankings, AbbVie's Q1 beat makes a case for more upside (XLV:NYSEARCA)

Noticias del mercado